A study [ 96 ] enrolled 472 patients with cancer which were supplemented by a mixture of HMB, glutamine (GLN), and arginine (ARG) or by an isonitrogenous, isocaloric control showing a strong trend towards higher fat-free mass in HMB/ARG/GLN-supplemented patients compared with controls.
← all excerpts
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges.
1
—
—